MUDr. Jakub Strincl s.r.o.

At MUDr. Jakub Strincl s.r.o. in Liberec, clinical research in this area focuses on viral respiratory illness, especially respiratory syncytial virus (RSV) infection. The studies are designed to assess whether new treatment approaches can better reduce symptoms and limit disease progression in adults at risk for complications.

• Evaluation of a new therapy for RSV infection in non-hospitalized adults
• Assessment of clinical symptoms to understand how the infection develops over time
• Research aimed at improving care for patients with higher risk of respiratory complications

This work supports better treatment options for common viral respiratory diseases and helps clarify how emerging therapies may perform in everyday clinical settings.

Another important area of research at the site involves the digestive system, with attention to the impact of antibiotic therapy on the gut and related patient outcomes. The trial work here explores how supportive treatment may help preserve gut microbiota during antibiotic use in people being treated for erythema migrans, an early form of Lyme borreliosis.

• Study of Saccharomyces boulardii CNCM I-745 and its possible role in supporting gut health
• Investigation of antibiotic-related changes in the gut microbiota
• Research focused on improving patient tolerance and overall treatment experience during infection care

The research combines infectious disease care with digestive health, aiming to better understand how supportive approaches can reduce disruption to the intestinal ecosystem during treatment.

The site also contributes to studies in broader viral disease prevention, particularly influenza. This research evaluates whether vaccination can provide strong protection against confirmed influenza illness in older adults, a group that is more vulnerable to severe outcomes.

• Testing the effectiveness of an influenza vaccine in adults aged 65 and older
• Comparison with an established vaccine option to support prevention strategies
• Focus on reducing influenza A and influenza B disease in the community

These trials help strengthen prevention efforts for seasonal viral infections and support better protection for older patients.